Compile Data Set for Download or QSAR
Report error Found 184 Enz. Inhib. hit(s) with all data for entry = 10099
TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385611BDBM385611(US10287292, Compound 1.013 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385614BDBM385614(US10287292, Compound 1.014 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385617BDBM385617(US10287292, Compound 1.015 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385618BDBM385618(US10287292, Compound 1.016 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385619BDBM385619(US10287292, Compound 1.017 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385623BDBM385623(US10287292, Compound 1.019 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385625BDBM385625(US10287292, Compound 1.020 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385626BDBM385626(US10287292, Compound 1.021 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385627BDBM385627(US10287292, Compound 1.022 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385629BDBM385629(US10287292, Compound 1.023 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385630BDBM385630(US10287292, Compound 1.024 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385631BDBM385631(US10287292, Compound 1.025 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385633BDBM385633(US10287292, Compound 1.026 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385699BDBM385699(US10287292, Compound 1.028 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385597BDBM385597(US10287292, Compound 1.001 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385599BDBM385599(US10287292, Compound 1.003 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385602BDBM385602(US10287292, Compound 1.006 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385606BDBM385606(US10287292, Compound 1.009 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385610BDBM385610(US10287292, Compound 1.012 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385867BDBM385867(US10287292, Compound 1.045 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385868BDBM385868(US10287292, Compound 1.046 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385870BDBM385870(US10287292, Compound 1.048 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 514040BDBM514040(US11059825, Compound 1.049)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385872BDBM385872(US10287292, Compound 1.050 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385873BDBM385873(US10287292, Compound 1.051 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385874BDBM385874(US10287292, Compound 1.052 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385875BDBM385875(US10287292, Compound 1.053 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 514045BDBM514045(US11059825, Compound 1.054)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385877BDBM385877(US10287292, Compound 1.055 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385879BDBM385879(US10287292, Compound 1.057 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385880BDBM385880(US10287292, Compound 1.058 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385881BDBM385881(US10287292, Compound 1.059 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385882BDBM385882(US10287292, Compound 1.060 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385717BDBM385717(US10287292, Compound 1.029 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385738BDBM385738(US10287292, Compound 1.030 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385743BDBM385743(US10287292, Compound 1.031 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385805BDBM385805(US10287292, Compound 1.032 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 514025BDBM514025(US11059825, Compound 1.034)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385819BDBM385819(US10287292, Compound 1.035 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385823BDBM385823(US10287292, Compound 1.036 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385859BDBM385859(US10287292, Compound 1.037 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385860BDBM385860(US10287292, Compound 1.038 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385861BDBM385861(US10287292, Compound 1.039 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385862BDBM385862(US10287292, Compound 1.040 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385863BDBM385863(US10287292, Compound 1.041 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385864BDBM385864(US10287292, Compound 1.042 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385866BDBM385866(US10287292, Compound 1.044 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385898BDBM385898(US10287292, Compound 1.076 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385898BDBM385898(US10287292, Compound 1.076 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

TargetAtypical chemokine receptor 3(Human)
Chemocentryx

US Patent
LigandChemical structure of BindingDB Monomer ID 385899BDBM385899(US10287292, Compound 1.077 | US11059825, Compound ...)
Affinity DataIC50: 500nMAssay Description:Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/2/2022
Entry Details
US Patent

Displayed 1 to 50 (of 184 total ) | Next | Last >>
Jump to: